Tag Archives: Editas Medicine Inc.

Broad Institute, UC Berkeley fight CRISPR patent battle for untold $$$; hey IRS: where does nonprofit college end and for-profit business begin?

The News: The US Patent and Trademark Office (USPTO) on Wednesday (February 15, 2017) ruled in favor of the Broad Institute (Cambridge MA) of Harvard University and MIT regarding certain CRISPR-Cas9 patents,… Read more »

Global outlook for biotech IPOs looks bright; will “precision” and “convergence” be the new mantras?

Many investors typically start the New Year searching for prescient predictions. Armed with a raft of “foolproof” data they then take an oath to stick with new, rock-solid resolutions, usually,… Read more »